Ulcer disease

This study tests a liquid agent called Onyx™ that is injected into arteries to block active bleeding outside the heart and brain. It includes 119 adults with severe bleeding from trauma, ulcers, or other causes. The goal is to see if it safely stops bleeding without needing furth…

This study is testing a device called the TrueLok Elevate that uses a technique called transverse bone transport to help heal chronic lower limb ulcers. The device is attached to the leg and slowly moves a piece of bone to stimulate blood flow and tissue healing. Researchers will…

This study will follow 500 people with Crohn's disease or ulcerative colitis who are starting guselkumab, a biologic drug. Researchers will measure how many achieve remission and how the treatment affects daily life, including fatigue and work productivity. The goal is to underst…

This study tests a daily pill called etrasimod in 24 children aged 2 to 12 with moderate to severe ulcerative colitis, a chronic inflammatory bowel disease. The goal is to see if the drug can safely help children reach remission (few or no symptoms) over 52 weeks. Participants wh…

This trial is testing whether adding a patch made from pig placental tissue to standard wound care helps diabetic foot ulcers close faster than standard care alone. The study involves about 235 adults with diabetes who have a hard-to-heal foot ulcer. Participants are randomly ass…

This trial tests whether a coordinated team of hospital and community healthcare professionals can improve healing of hard-to-heal ulcers compared to standard care. Adults with such ulcers are randomly assigned to either the multidisciplinary team or usual treatment. The main goa…

This study looks at how well different starting doses of the oral drug propranolol heal ulcers in infantile hemangioma (a type of birthmark). About 40 children with ulcerated hemangiomas will receive either a standard or higher initial dose. The main goal is to see which dose lea…

This study will follow 100 people in Saudi Arabia with moderate to severe Crohn's disease or ulcerative colitis who are starting guselkumab. Researchers will measure how long patients continue the treatment in real-world clinics, along with early symptom improvements. No new drug…

This study tests a new antibiotic called telacebec for Buruli ulcer, a bacterial skin infection that can cause large open sores. About 200 adults will take telacebec tablets for 14 to 28 days. Researchers will check if the ulcers heal completely within a year without needing surg…

This study tests whether adding special wound dressings (called CAMPs) to standard care helps heal pressure ulcers (bedsores) that won't close on their own. About 2,000 adults with stage 3 or 4 pressure sores will receive weekly applications of a CAMP product plus standard care, …

This study tests a new way to treat marginal ulcers that can form after gastric bypass surgery. Instead of just taking standard acid-reducing medication, some participants will also receive a low-thermal argon plasma treatment during an endoscopy. The goal is to see if this plasm…

This study tests whether a special placental graft, used alongside standard wound care, helps close diabetic foot ulcers that won't heal on their own. About 350 adults with type 1 or 2 diabetes and a foot ulcer between 1 and 15 cm² will be randomly assigned to get the graft plus …

This study tests whether special wraps made from human placental membrane can help heal diabetic foot ulcers and venous leg ulcers that won't close on their own. About 50 adults with diabetes or venous disease will receive weekly applications of one of four placental membrane pro…

This study is testing a special soft cast for people with diabetic foot ulcers. The cast is a multi-layer wrap that cushions the foot and leg to help the wound heal. Researchers want to see if it works well, is comfortable, and safe. About 100 adults with diabetic foot ulcers wil…

Researchers are testing whether a mouthwash made from copaiba oil, combined with low-level laser therapy, can prevent oral mucositis in people undergoing autologous hematopoietic stem cell transplantation. Oral mucositis is a common and painful side effect of the high-dose chemot…

This study tests a daily light therapy device placed inside the mouth to prevent severe mouth sores in people receiving a stem cell transplant. Twenty adults will use the device for about 2-3 minutes each day from the start of their conditioning chemotherapy through day 20 after …

This trial tests whether infrared laser therapy can relieve pain and speed healing in people with chronic venous leg ulcers — slow-healing wounds on the lower leg caused by poor blood flow. About 20 adults with ulcers lasting more than four weeks will receive either real laser tr…

This phase 2 trial is testing a topical gel and mouthwash made from olive oil, betaine, and xylitol (XCM-OM118) to see if it can reduce severe oral mucositis (painful mouth sores) in head & neck cancer patients receiving radiation. The study will enroll 63 adults and track how ma…

This study tests a device that delivers oxygen to chronic leg ulcers caused by vein problems. About 212 adults will get either the real oxygen therapy or a sham treatment, along with standard compression bandages, for up to 16 weeks. The main goal is to see if the oxygen therapy …

This study follows 50 people whose diabetic foot ulcers healed in a previous trial. They will use a BlueDrop foot scanner at home each morning to take photos and thermal images, which are sent to a nurse. The goal is to see how often the ulcers come back and whether remote monito…